STOCK TITAN

Psychemedics Stock Price, News & Analysis

PMD NASDAQ

Company Description

Company Overview

Psychemedics Corp (PMD) is a globally recognized provider of advanced drug testing and hair analysis solutions, specializing in the detection of drugs of abuse. With decades of industry experience, the company has built a reputation for accuracy, reliability, and innovation in substance abuse detection, remaining at the forefront of a critical market segment for employers, law enforcement agencies, educational institutions, and public organizations.

Core Business and Technology

Psychemedics utilizes a proprietary, patented hair testing methodology that offers significant advantages over traditional drug testing methods. Its process captures long-term drug use patterns and provides more definitive results compared to urine tests. This robust testing technology helps organizations ensure safe work environments and maintain strict compliance standards through scientifically validated methods.

Drug Testing Methodology

The company's core competency lies in its hair testing process, which has been refined over three decades. This innovative approach not only mitigates the limitations typically associated with short-term detection windows but also facilitates the discovery of a broad spectrum of substances, including emerging challenges such as ketamine abuse. By leveraging advanced analytical techniques, Psychemedics enables precise and dependable detection results, ensuring a high level of confidence in their test outcomes.

Innovative Reporting Solutions

Innovation is a hallmark of Psychemedics' service offerings. The introduction of new features like Quartile Reporting underscores the company's commitment to transforming raw data into actionable insights. With this analytical tool, organizations can contextualize individual drug test results within broader statistical frameworks, segmenting outcomes into quartiles to facilitate clearer interpretations of trends and patterns in substance use. This evolution in reporting reflects a deep understanding of the operational challenges faced by clients and underscores a collaborative approach to modernizing drug testing services.

Market Position and Customer Base

Having served a global clientele for decades, Psychemedics holds a prestigious position within the drug testing industry. Its services are employed by a diverse clientele that includes major corporations, several top-tier public and private institutions, and influential governmental bodies. The company's emphasis on quality and regulatory compliance has established it as a trusted partner for organizations that demand rigorous and scientifically sound testing protocols.

Competitive Landscape and Differentiation

In an industry where various testing methods and providers exist, Psychemedics differentiates itself through the specificity and accuracy of its hair analysis technique. The company is known not only for providing reliable drug detection services but also for innovating industry standards. Its robust patent portfolio and continuous development of advanced testing methodologies allow it to stay agile in a competitive market, maintaining a unique value proposition compared to traditional methods.

Industry Expertise and Operational Excellence

Psychemedics demonstrates deep industry knowledge through its ongoing focus on research and development. This expertise is evident in its ability to adapt to emerging drug trends and incorporate cutting-edge technologies into its testing procedures. The company's operational excellence is reflected in its meticulous quality control protocols, extensive validation processes, and an unwavering focus on delivering unbiased, precise results across various sectors.

Commitment to Quality and Compliance

Quality and accuracy are the cornerstones of Psychemedics' operational framework. The company's testing services adhere to the highest standards of scientific integrity and are backed by rigorous quality controls to ensure compliance with industry regulations. By providing transparent, verifiable results, Psychemedics helps organizations manage risk, foster safer environments, and enforce workplace standards effectively.

Conclusion

Overall, Psychemedics Corp (PMD) stands as a beacon of innovation and reliability within the drug testing industry. Its advanced hair analysis technology, comprehensive testing services, and continuous commitment to refining its methods empower organizations worldwide to achieve safer and more compliant operational environments. The clarity and precision offered by its innovative reporting systems further cement the company's role as a trusted, industry-defining entity in substance abuse detection.

Stock Performance

$—
0.00%
0.00
Last updated:
-40 %
Performance 1 year
$15.7M
Market Cap
5.9M
Shares outstanding

SEC Filings

No SEC filings available for Psychemedics.

Financial Highlights

$5,175,000
Revenue (TTM)
-$535,000
Net Income (TTM)
$263,000
Operating Cash Flow
-10.34%
Net Profit Margin
-11.50%
Oper. Profit Margin
39.40%
Gross Profit Margin

Upcoming Events

Frequently Asked Questions

What is the current stock price of Psychemedics (PMD)?

The current stock price of Psychemedics (PMD) is $2.67 as of January 24, 2025.

What is the market cap of Psychemedics (PMD)?

The market cap of Psychemedics (PMD) is approximately 15.7M.

What is the revenue (TTM) of Psychemedics (PMD) stock?

The trailing twelve months (TTM) revenue of Psychemedics (PMD) is $5,175,000.

What is the net income of Psychemedics (PMD)?

The trailing twelve months (TTM) net income of Psychemedics (PMD) is -$535,000.

What is the operating cash flow of Psychemedics (PMD)?

The operating cash flow of Psychemedics (PMD) is $263,000.

What is the profit margin of Psychemedics (PMD)?

The net profit margin of Psychemedics (PMD) is -10.34%.

What is the operating margin of Psychemedics (PMD)?

The operating profit margin of Psychemedics (PMD) is -11.50%.

What is the gross margin of Psychemedics (PMD)?

The gross profit margin of Psychemedics (PMD) is 39.40%.

What is the current ratio of Psychemedics (PMD)?

The current ratio of Psychemedics (PMD) is 1.59, indicating the company's ability to pay short-term obligations.

What is the gross profit of Psychemedics (PMD)?

The gross profit of Psychemedics (PMD) is $2,039,000 on a trailing twelve months (TTM) basis.

What is the operating income of Psychemedics (PMD)?

The operating income of Psychemedics (PMD) is -$595,000.

What is Psychemedics Corp known for?

Psychemedics Corp specializes in providing advanced hair analysis for drug testing. The company is renowned for its patented technology and decades of industry expertise, serving a diverse range of institutions.

How does the hair testing process work?

The hair testing process involves analyzing hair samples to detect long-term patterns of drug use. This method overcomes the limitations of traditional urine tests by providing a broader detection window and more conclusive results.

Who are the primary clients of Psychemedics?

Psychemedics serves a global customer base that includes major corporations, law enforcement agencies, educational institutions, and public entities. Its services are valued by organizations requiring reliable and scientifically validated drug testing.

How does the company's ketamine testing enhance its offerings?

The ketamine testing service is an extension of Psychemedics' commitment to addressing emerging drug challenges. This service equips organizations with the ability to effectively detect and manage the risks associated with ketamine abuse.

What is Quartile Reporting and how does it benefit clients?

Quartile Reporting is an innovative feature that segments drug test results into four quartiles, providing clients with a clear context of where an individual's results fall within industry benchmarks. This advanced reporting aids in better decision-making and trend analysis.

How do Psychemedics' testing methods compare to traditional urine tests?

Psychemedics' hair testing method offers a longer detection window and higher specificity compared to traditional urine tests. This allows for more accurate and comprehensive drug use profiling over an extended period.

What makes Psychemedics a trusted partner in drug testing?

The company's long-standing track record, rigorous quality control measures, and continuous innovation in testing technology make it a trusted provider. Its adherence to strict scientific standards ensures reliable and verifiable results.

How does Psychemedics ensure compliance with industry regulations?

Psychemedics follows robust quality control processes and scientific validation protocols that meet industry regulations. By maintaining high standards of accuracy and transparency, the company ensures that its testing methods are compliant and reliable.